Functional studies of the ATP-sensitive potassium channel.
In plain English
AI plain-English summaryA faulty ion channel in the pancreas can lock insulin production into a dangerous on-off cycle that leaves some newborns with diabetes. The channel, called KATP, normally acts as a metabolic sensor in cells, adjusting their electrical activity based on available energy. When mutations in the channel’s subunits—Kir6.2 and SUR1—make it overactive, the cell fails to release insulin, causing neonatal diabetes. In some patients the condition is permanent; in others it disappears only to return later in life. A few also develop neurological problems. This research aims to map exactly how the channel’s structure controls its gating—how it opens and closes in response to nucleotides and drugs—and how specific mutations disrupt that process. Using mouse models, the team will also explore three puzzles from human patients: why sulphonylurea drugs work better with oral glucose than intravenous glucose; why diabetes can remit and relapse; and why some mutations cause brain symptoms alongside diabetes. The work is fundamental science. It will not produce a new treatment tomorrow. But understanding the precise mechanics of KATP channels has already led to drug therapies for diabetes, and deeper knowledge of gating could eventually guide better drugs for neonatal diabetes and related metabolic disorders.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Programme GrantPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know